Fig. 2From: Points to consider: efficacy and safety evaluations in the clinical development of ultra-orphan drugsThe numbers of RCTs conducted. Upper panel: Ultra-orphan drugs. Lower panel: Orphan drugs other than ultra-orphan drugs. The numbers in the figure are the numbers of drugs. RCTs: randomized controlled trialsBack to article page